Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma

Published:2016-03-30 Issue:9 Volume:23 Page:718-729
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Lu Mei¹,Li Jia¹,Rupp Loralee B.²,Holmberg Scott D.³,Moorman Anne C.³,Spradling Philip R.³,Teshale Eyasu H.³,Zhou Yueren¹,Boscarino Joseph A.⁴,Schmidt Mark A.⁵,Lamerato Lois E.¹,Trinacty Connie⁶,Trudeau Sheri¹,Gordon Stuart C.⁷,

Affiliation:

1. Department of Public Health Sciences; Henry Ford Health System; Detroit MI USA

2. Center for Health Policy and Health Services Research; Henry Ford Health System; Detroit MI USA

3. Division of Viral Hepatitis; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Centers for Disease Control and Prevention; Atlanta GA USA

4. Center for Health Research; Geisinger Health System; Danville PA USA

5. Center for Health Research; Kaiser Permanente-Northwest; Portland OR Portland

6. Center for Health Research; Kaiser Permanente-Hawai'i; Waipahu HI USA

7. Division of Gastroenterology and Hepatology; Henry Ford Health System; Detroit MI USA

Funder

Centers for Disease Control and Prevention

AbbVie

Gilead Sciences

Janssen Pharmaceuticals

Genentech

Vertex Pharmaceuticals

Bristol-Myers Squibb

GlaxoSmithKline

Intercept Pharmaceuticals

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12538/fullpdf

Reference33 articles.

1. Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review;Yau;Can J Gastroenterol Hepatol,2014

2. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis;Aleman;Clin Infect Dis,2013

3. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon;Di Bisceglie;N Engl J Med,2008

4. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group;Imai;Ann Intern Med,1998

5. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy;Shindo;Cancer,1999

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens;Viruses;2023-03-04

2. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals;Cancers;2022-05-30

3. Risk of hepatocellular carcinoma after hepatitis C virus cure;World Journal of Gastroenterology;2022-01-07

4. Race and Gender Disparity in the Surgical Management of Hepatocellular Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Program Registry;World Journal of Surgery;2021-04-23

5. A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma;The Oncologist;2020-11-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3